β-catenin regulates IRF3-mediated innate immune signalling in colorectal cancer

Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells

(2017) Wan Huai Teo et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β

(2017) Masataka Sakisaka et al.   Journal of Hepato-Biliary-Pancreatic Sciences

cGAS is essential for the antitumor effect of immune checkpoint blockade

(2017) Hua Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The combination of bleomycin with suicide or interferon-β gene transfer is able to efficiently eliminate human melanoma tumor initiating cells

(2016) Chiara Fondello et al.   BIOMEDICINE & PHARMACOTHERAPY

A Viral Deamidase Targets the Helicase Domain of RIG-I to Block RNA-Induced Activation

(2016) Jun Zhao et al.   Cell Host & Microbe

The microbiome and innate immunity

(2016) Christoph A. Thaiss et al.   NATURE

Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing

(2016) Qi Chen et al.   NATURE IMMUNOLOGY

Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells

(2016) P Shou et al.   ONCOGENE

Host cytoskeleton in respiratory syncytial virus assembly and budding

(2016) Shadi Shahriari et al.   Virology Journal

Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β

(2016) N Yoon et al.   Cell Death & Disease

Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs

(2016) Diana Rose E. Ranoa et al.   Oncotarget

IFN -Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses

(2016) F. S. Basingab et al.   Cancer Immunology Research

The paradoxical role of IL-10 in immunity and cancer

(2015) Mark H. Mannino et al.   CANCER LETTERS

TGF  Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response

(2015) J. Han et al.   CANCER RESEARCH

Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection

(2015) Ren-Huan Xu et al.   IMMUNITY

β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling

(2014) Andrea Hillesheim et al.   Cell Communication and Signaling

GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses

(2013) Hao-Sen Chiang et al.   NATURE IMMUNOLOGY

IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8+ T cell responses to influenza A virus

(2013) Iris K Pang et al.   NATURE IMMUNOLOGY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

NEDD4L Is Downregulated in Colorectal Cancer and Inhibits Canonical WNT Signaling

(2013) Jarred P. Tanksley et al.   PLoS One

β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis

(2012) Joseph Rosenbluh et al.   CELL

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

A New Approach to Reducing Postsurgical Cancer Recurrence: Perioperative Targeting of Catecholamines and Prostaglandins

(2012) E. Neeman et al.   CLINICAL CANCER RESEARCH

β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury

(2012) Bibo Ke et al.   HEPATOLOGY

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens

(2012) Marie Lafitte et al.   Molecular Cancer

DAI (DLM-1/ZBP1) as a Genetic Adjuvant for DNA Vaccines That Promotes Effective Antitumor CTL Immunity

(2010) Alvaro Lladser et al.   MOLECULAR THERAPY

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

(2008) Ron Firestein et al.   NATURE